Atherosclerosis assessment and rheumatoid arthritis

Area of Science:

• Cardiovascular disease research
• Rheumatology
• Biochemistry

Background:

• Rheumatoid arthritis (RA) is linked to higher rates of atherosclerotic cardiovascular diseases.
• Lipoprotein-associated phospholipase A2 (Lp-PLA2) is implicated in inflammatory processes and atherosclerosis development.
• Understanding Lp-PLA2's role in RA-associated cardiovascular risk is crucial.

Purpose of the Study:

• To investigate the association between Lp-PLA2 activity and atherosclerosis in RA patients.
• To compare Lp-PLA2 activity and carotid intima-media thickness (CIMT) in RA patients versus controls.

Main Methods:

• Serum Lp-PLA2 activity was measured in 25 RA patients, 20 type 2 diabetes mellitus (DM) patients, and 20 healthy controls.
• Carotid intima-media thickness (CIMT) was assessed in all participants.
• Disease Activity Score 28 (DAS28) was used to evaluate disease activity in RA patients.

Main Results:

• Lp-PLA2 activity was significantly higher in the DM group compared to others (p=0.006).
• Mean CIMT was significantly higher in type 2 DM patients (p=0.047).
• Low-density cholesterol levels were lower in RA and healthy controls compared to diabetics.

Conclusions:

• Lp-PLA2 activity was not elevated in RA patients compared to healthy controls or the DM group.
• The lack of increased Lp-PLA2 activity in RA patients may be linked to their lower disease activity scores.
• Further research is needed to fully elucidate Lp-PLA2's role in RA pathogenesis and cardiovascular risk.